• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

Santen moving


Santen Inc. is moving its U.S. corporate headquarters from Napa, CA, to Emeryville, CA, in July.

Napa, CA-Santen Inc. is moving its U.S. corporate headquarters from Napa, CA, to Emeryville, CA, in July. The company is a wholly-owned subsidiary of Santen Pharmaceutical Co., Ltd., Osaka, Japan.

“In the preparation of our new strategic plan, we can see that there will be substantial expansion of the organization, and we could not have accommodated this growth in the existing facility in Napa,” said Akihiro Tsujimura, chief operating officer of Santen Inc. “Since we will experience a significant demand for new staff, we believe that the new location will make it easier to recruit the highest-quality talent, as we will have increased access to the greater San Francisco Bay area biopharmaceutical talent pool.”

A secondary reason for the relocation, according to company officials, was the need for convenient access to international transportation due to increased interaction with the company’s employees in Japan and Europe.

Santen will occupy nearly 50,000 square feet on the top two floors of a 16-story building.

Related Videos
Video 2 - 1 KOL is featured in, "Advances in Technology for SMILE procedure"
Video 1 - 1 KOL is featured in, "Overview of Small Incision Lenticule Extraction (SMILE)"
Vicki Chan, MD, shares pearls for leveraging the power of social media in health care
EyeCon 2024: Peter J. McDonnell, MD, marvels on mentoring, modern technology, and ophthalmology’s future
Lorraine Provencher, MD, presenting slides
© 2024 MJH Life Sciences

All rights reserved.